Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In vivo CRISPR activation screen identifies a lipid metabolism regulator as a driver of bone metastasis

ABSTRACT: In vivo CRISPR activation screen identifies a lipid metabolism regulator as a driver of bone metastasis

PROVIDER: PRJNA1052719 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27214490.fastq.gz	Fastqsanger.gz
	SRR27214491.fastq.gz	Fastqsanger.gz
	SRR27214492.fastq.gz	Fastqsanger.gz
	SRR27214493.fastq.gz	Fastqsanger.gz
	SRR27214494.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

In vivo CRISPR activation screen identifies a lipid metabolism regulator as a driver of bone metastasis

Project description:The role of lipid metabolism in bone metastasis has not been documented. Here, by using an in vivo CRISPR activation screening system coupled with positive selection, we identify acyl-CoA binding protein (ACBP) as a previously undescribed bone metastasis driver. In non-metastatic cancer cells, overexpression of wild-type ACBP, but not the acyl-CoA binding deficient mutant, stimulates fatty acid oxidation (FAO) and bone metastasis. Conversely, knockout of ACBP in highly bone-metastatic cells abrogates metastatic bone colonization. Mechanistically, ACBP-mediated FAO boosts ATP and NADPH production, reduces reactive oxygen species, and inhibits lipid peroxidation and ferroptosis. ACBP expression correlates with metabolic signaling, bone-metastatic ability, and poor clinical outcomes. Notably, FAO blockade or treatment with a ferroptosis inducer inhibits bone metastasis. Altogether, our findings reveal the role of lipid metabolism in tumor cell adaptation and thriving in the bone, and suggests that agents that target FAO or induce ferroptosis hold potential as bone metastasis drugs.

2025-05-07 | GSE250240 | GEO

Chromatin regulator SMARCAL1 modulates cellular lipid metabolism

Project description:Chromatin regulator SMARCAL1 modulates cellular lipid metabolism

| PRJNA914046 | ENA

NSD2 is an actionable driver of prostate cancer metastasis

Project description:NSD2 is an actionable driver of prostate cancer metastasis

| PRJNA487359 | ENA

A metabolic co-regulator bioinformatics screen reveals that PGC1Î± suppresses prostate cancer metastasis

Project description:The current view of cellular transformation and cancer progression supports the notion that cancer cells must reprogram their metabolism in order to survive and progress in different microenvironments. Master co-regulators of metabolism orchestrate the modulation of multiple metabolic pathways through transcriptional programs, and hence constitute a probabilistically parsimonious mechanism for general metabolic rewiring. Here we show that the transcriptional co-activator PGC1Î± suppresses prostate cancer progression and metastasis. A metabolic co-regulator data mining analysis unveiled that PGC1Î± is consistently down-regulated in multiple prostate cancer patient datasets and its alteration is associated with reduced disease-free survival and metastasis. Genetically engineered mouse model studies revealed that compound prostate epithelium-specific deletion of Pgc1a and Pten promotes prostate cancer progression and metastasis, whereas, conversely, PGC1Î± expression in cell lines inhibits the pre-existing metastatic capacity. Through the application of integrative metabolomics and transcriptomics we demonstrate that PGC1Î± expression in prostate cancer is sufficient to elicit a global metabolic rewiring that opposes cell growth, consisting of sustained oxidative metabolism at the expense of anabolism. This metabolic program is regulated downstream the Oestrogen-related receptor alpha (ERRÎ±), and PGC1Î± mutants lacking ERRÎ± activation capacity lack metabolic rewiring capacity and metastasissuppressive function. Importantly, an ERRÎ± signature in prostate cancer recapitulates the prognostic features of PGC1A. Our findings uncover an unprecedented causal contribution of PGC1Î± to the metabolic switch in prostate cancer and to the suppression of metastatic dissemination. Total RNA was isolated from prostate cancer cell line PC3 expressing or not PGC1a (for induction, cells were treated with doxycycline for 2 passages)

2016-03-16 | E-GEOD-75193 | biostudies-arrayexpress

Epigenetic screen of metastasis-driving genes in osteosarcoma

Project description:Epigenetic screen of metastasis-driving genes in osteosarcoma

| PRJNA242750 | ENA

NAT10 is identified as a novel driver for brain metastasis

Project description:NAT10 is identified as a novel driver for brain metastasis

| PRJNA1120428 | ENA

Chromatin regulator SMARCAL1 modulates cellular lipid metabolism

Project description:Biallelic mutations of the chromatin regulator SMARCAL1 cause Schimke Immunoosseous Dysplasia (SIOD), characterized by severe growth defects and premature mortality. Atherosclerosis and hyperlipidemia are common among SIOD patients, yet their onset and progression are poorly understood. Using an integrative approach involving proteomics, mouse models, and population genetics, we investigated SMARCAL1's role. We found that SmarcAL1 interacts with angiopoietin-like 3 (Angptl3), a key regulator of lipoprotein metabolism. In vitro and in vivo analyses demonstrate SmarcAL1's vital role in maintaining cellular lipid homeostasis. The observed translocation of SmarcAL1 to cytoplasmic peroxisomes suggests a potential regulatory role in lipid metabolism through gene expression. SmarcAL1 gene inactivation reduces the expression of key genes in cellular lipid catabolism. Population genetics investigations highlight significant associations between SMARCAL1 genetic variations and body mass index, along with lipid-related traits. This study underscores SMARCAL1's pivotal role in cellular lipid metabolism, likely contributing to the observed lipid phenotypes in SIOD patients.

2025-02-19 | GSE221372 | GEO

Pancreatic Circulating Tumour Cell Profiling Identifies LIN28B as a Metastasis Driver and Drug Target

Project description:Gene expression profiling of circulating tumor cells purified from human patients with pancreatic cancer led to identification of LIN28B as possible metastasis driver. Functional studies in model systems confirmed the importance of this pathway.

2020-03-01 | GSE144561 | GEO

Stromal lipid species dictate melanoma metastasis and tropism [MFP_RNA_seq]

Project description:Stromal lipid species dictate melanoma metastasis and tropism [MFP_RNA_seq]

| PRJNA1240333 | ENA

Stromal lipid species dictate melanoma metastasis and tropism [MeWo_RNA_seq]

Project description:Stromal lipid species dictate melanoma metastasis and tropism [MeWo_RNA_seq]

| PRJNA1240334 | ENA